Skip to content
Disclosery

Privium Fund Management B.V.

Follow

13F filer, CIK 1795097, AMSTERDAM, Netherlands

Privium Fund Management B.V. reported $544,216,295 across 61 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-07. Its ten largest share positions make up 61.81% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001754960-26-000698

Period
2026-06-30
Reported value
$544M
Holdings
61
Top 10 weight
61.81%
New
12
Sold out
11

Largest buys vs the previous quarter

SecurityShares changeApprox. value
OPENnew+3,940,904$18.2M
CBRSnew+60,500$13.4M
SPCXnew+40,000$6.83M
AMZNadded+15,000$3.58M
TSLAadded+6,000$2.52M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
COINexited-79,000-$13.8M
SEexited-138,000-$11.4M
ARWRreduced-132,714-$10.8M
ESPRexited-3,299,441-$9.04M
QUREreduced-158,198-$7.29M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001754960-26-000698, largest first. % of portfolio is the value over $544,216,295, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
TSLATESLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 216,000 shares; 2024Q4: 220,000 shares; 2025Q1: 220,000 shares; 2025Q2: 242,000 shares; 2025Q3: 244,000 shares; 2025Q4: 228,500 shares; 2026Q1: 222,000 shares; 2026Q2: 228,000 shares 228,000$95.9M17.62%+6,000Timeline
SHOPSHOPIFY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 415,000 shares; 2024Q4: 415,000 shares; 2025Q1: 415,000 shares; 2025Q2: 430,000 shares; 2025Q3: 415,000 shares; 2025Q4: 410,000 shares; 2026Q1: 407,000 shares; 2026Q2: 370,000 shares 370,000$42.2M7.76%-37,000Timeline
AMDADVANCED MICRO DEVICES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 44,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 60,000 shares; 2025Q4: 60,000 shares; 2026Q1: 62,000 shares; 2026Q2: 62,000 shares 62,000$36M6.62%0Timeline
AMZNAMAZON COM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 141,000 shares; 2024Q4: 141,000 shares; 2025Q1: 141,000 shares; 2025Q2: 149,000 shares; 2025Q3: 149,000 shares; 2025Q4: 121,000 shares; 2026Q1: 125,000 shares; 2026Q2: 140,000 shares 140,000$33.4M6.13%+15,000Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 250,744 shares; 2024Q4: 266,794 shares; 2025Q1: 267,594 shares; 2025Q2: 267,594 shares; 2025Q3: 248,894 shares; 2025Q4: 240,824 shares; 2026Q1: 290,024 shares; 2026Q2: 319,924 shares 319,924$25.4M4.66%+29,900Timeline
SPOTSPOTIFY TECHNOLOGY S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 149,000 shares; 2024Q4: 145,000 shares; 2025Q1: 145,000 shares; 2025Q2: 114,000 shares; 2025Q3: 95,000 shares; 2025Q4: 68,000 shares; 2026Q1: 67,000 shares; 2026Q2: 55,000 shares 55,000$25.3M4.64%-12,000Timeline
PLTRPALANTIR TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 475,000 shares; 2024Q4: 370,000 shares; 2025Q1: 360,000 shares; 2025Q2: 350,000 shares; 2025Q3: 200,000 shares; 2025Q4: 200,000 shares; 2026Q1: 200,000 shares; 2026Q2: 200,000 shares 200,000$23.3M4.29%0Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 333,356 shares; 2024Q4: 380,586 shares; 2025Q1: 629,214 shares; 2025Q2: 612,214 shares; 2025Q3: 473,951 shares; 2025Q4: 398,204 shares; 2026Q1: 366,936 shares; 2026Q2: 234,222 shares 234,222$19.1M3.51%-132,714Timeline
OPENOPENDOOR TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,940,904 shares 3,940,904$18.2M3.35%newTimeline
LMNDLEMONADE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 145,000 shares; 2025Q4: 248,259 shares; 2026Q1: 255,259 shares; 2026Q2: 270,259 shares 270,259$17.6M3.23%+15,000Timeline
NVDANVIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 73,000 shares; 2024Q4: 73,000 shares; 2025Q1: 73,000 shares; 2025Q2: 81,000 shares; 2025Q3: 81,000 shares; 2025Q4: 81,000 shares; 2026Q1: 81,000 shares; 2026Q2: 81,000 shares 81,000$16.2M2.98%0Timeline
IRENIREN LIMITEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 130,000 shares; 2025Q4: 280,000 shares; 2026Q1: 320,150 shares; 2026Q2: 340,150 shares 340,150$15.6M2.86%+20,000Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 744,916 shares; 2024Q4: 742,162 shares; 2025Q1: 579,139 shares; 2025Q2: 447,486 shares; 2025Q3: 386,000 shares; 2025Q4: 416,270 shares; 2026Q1: 486,520 shares; 2026Q2: 328,322 shares 328,322$15.1M2.78%-158,198Timeline
CBRSCEREBRAS SYSTEMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 60,500 shares 60,500$13.4M2.46%newTimeline
ASTSAST SPACEMOBILE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 821,267 shares; 2024Q4: 111,500 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 110,000 shares; 2025Q4: 145,000 shares; 2026Q1: 145,000 shares; 2026Q2: 145,000 shares 145,000$12.9M2.37%0Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 242,512 shares; 2024Q4: 258,380 shares; 2025Q1: 249,804 shares; 2025Q2: 253,304 shares; 2025Q3: 289,804 shares; 2025Q4: 357,502 shares; 2026Q1: 364,802 shares; 2026Q2: 338,800 shares 338,800$11.3M2.08%-26,002Timeline
ARQTARCUTIS BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 325,709 shares; 2025Q1: 325,709 shares; 2025Q2: 344,472 shares; 2025Q3: 305,972 shares; 2025Q4: 305,972 shares; 2026Q1: 320,972 shares; 2026Q2: 399,367 shares 399,367$10.5M1.92%+78,395Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 20,500 shares; 2025Q3: 51,925 shares; 2025Q4: 73,480 shares; 2026Q1: 43,800 shares; 2026Q2: 48,400 shares 48,400$10.5M1.92%+4,600Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 5,632,388 shares; 2024Q4: 4,985,633 shares; 2025Q1: 4,985,633 shares; 2025Q2: 4,997,562 shares; 2025Q3: 4,998,287 shares; 2025Q4: 5,357,762 shares; 2026Q1: 5,467,149 shares; 2026Q2: 5,520,024 shares 5,520,024$10.3M1.89%+52,875Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 80,232 shares; 2024Q4: 62,232 shares; 2025Q1: 52,732 shares; 2025Q2: 52,732 shares; 2025Q3: 52,732 shares; 2025Q4: 56,878 shares; 2026Q1: 58,729 shares; 2026Q2: 39,944 shares 39,944$9.78M1.8%-18,785Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 27,691 shares; 2025Q1: 107,622 shares; 2025Q2: 107,622 shares; 2025Q3: 196,622 shares; 2025Q4: 214,622 shares; 2026Q1: 238,122 shares; 2026Q2: 210,000 shares 210,000$7.73M1.42%-28,122Timeline
SPCXSPACE EXPLORATION TECHN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 40,000 shares 40,000$6.83M1.26%newTimeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 254,857 shares; 2026Q2: 229,857 shares 229,857$5.91M1.09%-25,000Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 8,300 shares; 2025Q2: 8,300 shares; 2025Q3: 8,300 shares; 2025Q4: 9,355 shares; 2026Q1: 11,355 shares; 2026Q2: 9,400 shares 9,400$4.67M0.86%-1,955Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 92,305 shares; 2026Q2: 75,000 shares 75,000$4.29M0.79%-17,305Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 6,350 shares; 2024Q4: 9,250 shares; 2025Q1: 7,510 shares; 2025Q2: 9,320 shares; 2025Q3: 12,170 shares; 2025Q4: 12,170 shares; 2026Q1: 11,170 shares; 2026Q2: 11,170 shares 11,170$4.15M0.76%0Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 5,716 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 12,222 shares; 2026Q2: 11,372 shares 11,372$3.42M0.63%-850Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 173,516 shares; 2026Q1: 173,516 shares; 2026Q2: 173,516 shares 173,516$3.19M0.59%0Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,987 shares; 2025Q3: 19,000 shares; 2025Q4: 33,300 shares; 2026Q1: 27,000 shares; 2026Q2: 30,100 shares 30,100$2.8M0.51%+3,100Timeline
HIMSHIMS & HERS HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,000 shares; 2025Q3: 40,000 shares; 2025Q4: 40,000 shares; 2026Q1: 40,000 shares; 2026Q2: 80,000 shares 80,000$2.77M0.51%+40,000Timeline
MGTXMEIRAGTX HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 213,960 shares; 2024Q4: 225,078 shares; 2025Q1: 117,000 shares; 2025Q2: 163,000 shares; 2025Q3: 163,000 shares; 2025Q4: 200,000 shares; 2026Q1: 212,112 shares; 2026Q2: 196,112 shares 196,112$2.65M0.49%-16,000Timeline
ABEVAMBEV SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 622,314 shares; 2024Q4: 652,357 shares; 2025Q1: 804,206 shares; 2025Q2: 795,786 shares; 2025Q3: 897,134 shares; 2025Q4: 1,063,174 shares; 2026Q1: 948,558 shares; 2026Q2: 802,167 shares 802,167$2.52M0.46%-146,391Timeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 39,400 shares; 2025Q3: not reported; 2025Q4: 43,000 shares; 2026Q1: 46,000 shares; 2026Q2: 136,500 shares 136,500$2.45M0.45%+90,500Timeline
CRSPCRISPR THERAPEUTICS AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 30,347 shares; 2024Q4: 34,997 shares; 2025Q1: 60,097 shares; 2025Q2: 44,700 shares; 2025Q3: 40,000 shares; 2025Q4: 42,874 shares; 2026Q1: 42,874 shares; 2026Q2: 44,974 shares 44,974$2.45M0.45%+2,100Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 61,000 shares; 2025Q4: 71,500 shares; 2026Q1: 63,982 shares; 2026Q2: 70,282 shares 70,282$2.41M0.44%+6,300Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 215,624 shares; 2024Q4: 185,062 shares; 2025Q1: 132,189 shares; 2025Q2: 132,189 shares; 2025Q3: 132,189 shares; 2025Q4: 132,189 shares; 2026Q1: 132,189 shares; 2026Q2: 122,189 shares 122,189$2.32M0.43%-10,000Timeline
MRNAMODERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 40,482 shares; 2024Q4: 82,476 shares; 2025Q1: 75,576 shares; 2025Q2: 103,433 shares; 2025Q3: 47,000 shares; 2025Q4: 49,594 shares; 2026Q1: 29,994 shares; 2026Q2: 29,994 shares 29,994$2.1M0.39%0Timeline
RNACCARTESIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 172,500 shares; 2026Q1: 179,114 shares; 2026Q2: 151,675 shares 151,675$1.58M0.29%-27,439Timeline
MICCMAGNUM ICE CREAM CO NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 98,221 shares 98,221$1.5M0.27%newTimeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 48,834 shares; 2024Q4: 88,000 shares; 2025Q1: 113,550 shares; 2025Q2: 135,550 shares; 2025Q3: 170,000 shares; 2025Q4: 193,010 shares; 2026Q1: 241,010 shares; 2026Q2: 241,010 shares 241,010$1.4M0.26%0Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 120,000 shares; 2024Q4: 134,900 shares; 2025Q1: 134,900 shares; 2025Q2: 134,900 shares; 2025Q3: 134,900 shares; 2025Q4: 164,900 shares; 2026Q1: 181,900 shares; 2026Q2: 198,900 shares 198,900$1.35M0.25%+17,000Timeline
ZTSZOETIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 17,322 shares 17,322$1.24M0.23%newTimeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 98,500 shares; 2024Q4: 121,000 shares; 2025Q1: 131,000 shares; 2025Q2: 197,458 shares; 2025Q3: 197,458 shares; 2025Q4: 210,000 shares; 2026Q1: 170,256 shares; 2026Q2: 90,110 shares 90,110$1.2M0.22%-80,146Timeline
FATEFATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 50,000 shares; 2024Q4: 87,000 shares; 2025Q1: 109,026 shares; 2025Q2: 111,090 shares; 2025Q3: 333,219 shares; 2025Q4: 369,100 shares; 2026Q1: 414,311 shares; 2026Q2: 414,311 shares 414,311$1.12M0.21%0Timeline
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 35,400 shares 35,400$1.02M0.19%newTimeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 294,800 shares; 2024Q4: 397,650 shares; 2025Q1: 432,760 shares; 2025Q2: 432,760 shares; 2025Q3: 432,760 shares; 2025Q4: 170,146 shares; 2026Q1: 242,146 shares; 2026Q2: 244,146 shares 244,146$835K0.15%+2,000Timeline
NOVNOV INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 37,925 shares; 2024Q4: 42,889 shares; 2025Q1: 49,745 shares; 2025Q2: 63,876 shares; 2025Q3: 63,876 shares; 2025Q4: 53,126 shares; 2026Q1: 42,026 shares; 2026Q2: 42,026 shares 42,026$780K0.14%0Timeline
BTGB2GOLD CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 103,598 shares; 2024Q4: 85,146 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 96,477 shares; 2026Q2: 195,083 shares 195,083$730K0.13%+98,606Timeline
TTETOTALENERGIES SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,723 shares 10,723$729K0.13%newTimeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 138,115 shares; 2025Q1: 160,198 shares; 2025Q2: 178,356 shares; 2025Q3: 192,356 shares; 2025Q4: 192,550 shares; 2026Q1: 205,000 shares; 2026Q2: 155,000 shares 155,000$722K0.13%-50,000Timeline
RIGTRANSOCEAN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 102,000 shares; 2025Q4: 139,604 shares; 2026Q1: 106,604 shares; 2026Q2: 145,604 shares 145,604$712K0.13%+39,000Timeline
MOHMOLINA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 8,140 shares; 2026Q2: 2,979 shares 2,979$681K0.13%-5,161Timeline
NUNU HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 44,000 shares 44,000$588K0.11%newTimeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 185,639 shares; 2024Q4: 231,674 shares; 2025Q1: 251,674 shares; 2025Q2: 294,142 shares; 2025Q3: 308,837 shares; 2025Q4: 326,245 shares; 2026Q1: 363,430 shares; 2026Q2: 363,430 shares 363,430$581K0.11%0Timeline
TDWTIDEWATER INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 5,350 shares; 2025Q3: 5,483 shares; 2025Q4: 5,483 shares; 2026Q1: 5,483 shares; 2026Q2: 8,683 shares 8,683$579K0.11%+3,200Timeline
LULULULULEMON ATHLETICA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,063 shares 5,063$578K0.11%newTimeline
SDSANDRIDGE ENERGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 23,300 shares; 2024Q4: 23,300 shares; 2025Q1: 23,300 shares; 2025Q2: 37,022 shares; 2025Q3: 50,392 shares; 2025Q4: 38,792 shares; 2026Q1: 38,792 shares; 2026Q2: 38,792 shares 38,792$531K0.1%0Timeline
SASEABRIDGE GOLD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 16,512 shares 16,512$425K0.08%newTimeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 21,645 shares; 2025Q2: 25,241 shares; 2025Q3: 45,000 shares; 2025Q4: 95,000 shares; 2026Q1: 120,000 shares; 2026Q2: 120,000 shares 120,000$420K0.08%0Timeline
ENGNENGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 170,000 shares 170,000$294K0.05%newTimeline
CSANCOSAN S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 52,000 shares 52,000$150K0.03%newTimeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
COINCOINBASE GLOBAL INC79,000$13.8Mshares
SESEA LTD138,000$11.4Mshares
ESPRESPERION THERAPEUTICS INC NE3,299,441$9.04Mshares
ENGNENGENE HOLDINGS INC352,087$2.4Mshares
STOKSTOKE THERAPEUTICS INC50,000$1.63Mshares
PFEPFIZER INC52,679$1.48Mshares
SLBSLB LIMITED18,451$948Kshares
SASEABRIDGE GOLD INC24,828$704Kshares
NENOBLE CORP PLC6,849$336Kshares
PAASPAN AMERN SILVER CORP3,900$213Kshares
URNMSPROTT FDS TR3,302$209Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001754960-26-000698 base2026-08-07acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001754960-26-000698 Quarter ended 2026-06-302026-08-07acceptance time not in the bulk data set
13F-HR 0001754960-26-000356 Quarter ended 2026-03-312026-05-05acceptance time not in the bulk data set
13F-HR 0001754960-26-000150 Quarter ended 2025-12-312026-02-03acceptance time not in the bulk data set
13F-HR 0001754960-25-000748 Quarter ended 2025-09-302025-11-04acceptance time not in the bulk data set
13F-HR 0001754960-25-000506 Quarter ended 2025-06-302025-07-30acceptance time not in the bulk data set
13F-HR 0001754960-25-000288 Quarter ended 2025-03-312025-05-09acceptance time not in the bulk data set
13F-HR 0001754960-25-000124 Quarter ended 2024-12-312025-02-11acceptance time not in the bulk data set
13F-HR 0001754960-24-000542 Quarter ended 2024-09-302024-11-01acceptance time not in the bulk data set
13F-HR 0001754960-24-000376 Quarter ended 2024-06-302024-08-01acceptance time not in the bulk data set
13F-HR 0001754960-24-000192 Quarter ended 2024-03-312024-04-30acceptance time not in the bulk data set
13F-HR/A 0001754960-24-000101 Quarter ended 2023-12-312024-02-26acceptance time not in the bulk data set
13F-HR 0001754960-24-000089 Quarter ended 2023-12-312024-02-13acceptance time not in the bulk data set
13F-HR 0001754960-23-000317 Quarter ended 2023-09-302023-11-06acceptance time not in the bulk data set
13F-HR 0001754960-23-000215 Quarter ended 2023-06-302023-07-26acceptance time not in the bulk data set
13F-HR/A 0001754960-23-000217 Quarter ended 2023-06-302023-07-26acceptance time not in the bulk data set
13F-HR 0001754960-23-000140 Quarter ended 2023-03-312023-05-03acceptance time not in the bulk data set
13F-HR 0001754960-23-000058 Quarter ended 2022-12-312023-02-03acceptance time not in the bulk data set
13F-HR 0001754960-22-000290 Quarter ended 2022-09-302022-11-03acceptance time not in the bulk data set
13F-HR 0001754960-22-000198 Quarter ended 2022-06-302022-07-28acceptance time not in the bulk data set
13F-HR 0001754960-22-000134 Quarter ended 2022-03-312022-05-10acceptance time not in the bulk data set
13F-HR 0001754960-22-000061 Quarter ended 2021-12-312022-02-09acceptance time not in the bulk data set